Published in Front Immunol on June 06, 2016
The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications. Front Immunol (2017) 0.75
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet (2012) 12.41
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Germinal centers. Annu Rev Immunol (1994) 10.85
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature (2008) 10.80
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet (2016) 10.08
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
Intraclonal generation of antibody mutants in germinal centres. Nature (1991) 7.39
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature (2007) 4.88
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med (2015) 4.79
The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity (2005) 4.72
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65
Cross-reacting antibodies enhance dengue virus infection in humans. Science (2010) 4.63
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol (2007) 4.46
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med (1970) 4.41
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med (1970) 4.30
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol (1995) 4.16
Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. Immunology (1965) 4.00
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 3.89
Structure of the immature dengue virus at low pH primes proteolytic maturation. Science (2008) 3.86
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis (2004) 3.81
Structures of immature flavivirus particles. EMBO J (2003) 3.62
B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity (2007) 3.55
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe (2010) 3.48
Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg (1990) 3.41
The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity (2007) 3.28
The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science (2008) 3.26
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity (2009) 2.98
Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis (2007) 2.89
IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol (1999) 2.73
Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol (2011) 2.68
B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol (2001) 2.57
Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients. J Virol Methods (1985) 2.56
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A (2012) 2.42
Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology (2009) 2.26
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis (2010) 2.24
Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. J Clin Invest (2004) 2.21
Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis (2010) 2.08
Immature dengue virus: a veiled pathogen? PLoS Pathog (2010) 2.04
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03
Functional anatomy of germinal centers. Am J Anat (1984) 2.00
The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med (2012) 1.95
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis (2011) 1.92
Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg (2009) 1.87
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol (2008) 1.85
Novel pathways of antigen presentation for the maintenance of memory. Int Immunol (1991) 1.85
Role of natural and immune IgM antibodies in immune responses. Mol Immunol (2000) 1.84
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol (2008) 1.77
B cell follicles and antigen encounters of the third kind. Nat Immunol (2010) 1.76
Dengue structure differs at the temperatures of its human and mosquito hosts. Proc Natl Acad Sci U S A (2013) 1.75
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol (2012) 1.74
Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg (1980) 1.65
Studies on the structure and permeability of the microvasculature in normal rat lymph nodes. Am J Pathol (1975) 1.64
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology (2004) 1.61
Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J Virol (1995) 1.60
Animal models of dengue virus infection. Viruses (2012) 1.60
Structural proteomics of dengue virus. Curr Opin Microbiol (2008) 1.57
Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol (1984) 1.54
Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol (2011) 1.51
Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. J Clin Virol (2004) 1.45
Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. J Immunol (1994) 1.45
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J (2010) 1.43
Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol (2001) 1.42
Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol (2010) 1.41
Response to dengue fever--the good, the bad, and the ugly? N Engl J Med (2010) 1.40
Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl Trop Dis (2012) 1.39
Recombinant interferon-gamma induces interleukin 2 receptors on human peripheral blood monocytes. J Immunol (1986) 1.27
Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol (2002) 1.25
Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol (2011) 1.22
Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20
Isolated follicular dendritic cells: cytochemical antigen localization, Nomarski, SEM, and TEM morphology. J Immunol (1985) 1.15
Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol (2005) 1.15
Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis. J Infect Dis (2006) 1.12
The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett (2010) 1.11
B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health (1999) 1.09
Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur J Immunol (2009) 1.08
Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo. J Med Virol (2009) 1.08
Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody. J Med Virol (2001) 1.06
Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes. J Immunol (2012) 1.06
Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum Pathol (2014) 1.06
B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis (2011) 1.04
The microanatomy of B cell activation. Curr Opin Immunol (2009) 1.04
IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. J Immunol (1992) 1.04
Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog (2014) 1.01
Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. PLoS One (2011) 1.01
Characteristics of dengue virus-infected peripheral blood mononuclear cell death that correlates with the severity of illness. Microbiol Immunol (2009) 1.01
Macrophage functions during dengue virus infection: antigenic stimulation of B cells. Immunology (1987) 0.99
Antigen presentation the macrophage way. Cell (2007) 0.98
Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Virology (2010) 0.96
Immunohistochemical characterization of a new monoclonal antibody reactive with dengue virus-infected cells in frozen tissue using immunoperoxidase technique. Asian Pac J Allergy Immunol (1996) 0.96
Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients. J Immunol (2012) 0.95